Kusuda, Yuji <br/><br/>
Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens.  [electronic resource] 

 -  Urologic oncology  Jan 2013 
 - 42-50 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2496 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2010.09.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Bone Neoplasms--metabolism<br/>Carcinoma, Renal Cell--metabolism<br/>Combined Modality Therapy<br/>Disease Progression<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Kidney Neoplasms--metabolism<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Nephrectomy--mortality<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Prognosis<br/>Sorafenib<br/>Survival Rate